Home
>
National Drug Code (NDC)
>
Valsartan and hydrochlorothiazide
Valsartan and hydrochlorothiazide - 0591-2315-19 - (Valsartan and hydrochlorothiazide)
Drug Information of Valsartan and hydrochlorothiazide
| Product NDC: | 0591-2315 |
| Proprietary Name: | Valsartan and hydrochlorothiazide |
| Non Proprietary Name: | Valsartan and hydrochlorothiazide |
| Active Ingredient(s): | 12.5; 80 mg/1; mg/1 & nbsp; Valsartan and hydrochlorothiazide |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Valsartan and hydrochlorothiazide
| Product NDC: | 0591-2315 |
| Labeler Name: | Watson Laboratories, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA091519 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20130321 |
Package Information of Valsartan and hydrochlorothiazide
| Package NDC: | 0591-2315-19 |
| Package Description: | 90 TABLET, FILM COATED in 1 BOTTLE (0591-2315-19) |
NDC Information of Valsartan and hydrochlorothiazide
| NDC Code | 0591-2315-19 |
| Proprietary Name | Valsartan and hydrochlorothiazide |
| Package Description | 90 TABLET, FILM COATED in 1 BOTTLE (0591-2315-19) |
| Product NDC | 0591-2315 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Valsartan and hydrochlorothiazide |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20130321 |
| Marketing Category Name | ANDA |
| Labeler Name | Watson Laboratories, Inc. |
| Substance Name | HYDROCHLOROTHIAZIDE; VALSARTAN |
| Strength Number | 12.5; 80 |
| Strength Unit | mg/1; mg/1 |
| Pharmaceutical Classes | Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient],Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC] |
